A study on the optimal length of actigraphic recording in narcolepsy type 1.

Actigraphy Motor activity Narcolepsy Sleep Sleep latency

Journal

Clinical neurophysiology practice
ISSN: 2467-981X
Titre abrégé: Clin Neurophysiol Pract
Pays: Netherlands
ID NLM: 101684308

Informations de publication

Date de publication:
2019
Historique:
received: 07 01 2019
revised: 15 04 2019
accepted: 17 04 2019
entrez: 19 6 2019
pubmed: 19 6 2019
medline: 19 6 2019
Statut: epublish

Résumé

The aim of the present study was to assess the optimal length of actigraphic recordings in patients with narcolepsy type 1. A secondary analysis was carried out with the previously collected data in eleven patients with narcolepsy type 1. Ten of the 11 patients were medicated at the time of actigraphic recording. Each patient originally wore an Actiwatch AW64 actigraph for at least 28 consecutive days. Overall, the patients were analyzed for 308 nights. No significant differences were observed between the mean values of the 7-day and 14-day analyzed sets for the parameters sleep efficiency, fragmentation index, sleep onset latency, wake after sleep onset, and total sleep time. Our data suggest that 7 days of actigraphic recording could be sufficient for these patients. Our results for the optimal length of actigraphic recording could be useful for both physicians and patients.

Identifiants

pubmed: 31211287
doi: 10.1016/j.cnp.2019.04.004
pii: S2467-981X(19)30017-4
pmc: PMC6562260
doi:

Types de publication

Journal Article

Langues

eng

Pagination

114-118

Références

Sleep Med. 2018 Dec;52:88-91
pubmed: 30286385
Sleep. 2016 May 01;39(5):1047-50
pubmed: 26856902
J Clin Sleep Med. 2018 Jul 15;14(7):1209-1230
pubmed: 29991438
Sleep. 2009 Jun;32(6):767-71
pubmed: 19544753
J Psychosom Res. 2019 Feb;117:30-31
pubmed: 30665593
Chronobiol Int. 2014 Apr;31(3):356-62
pubmed: 24304408
Sleep Med. 2015 Jan;16(1):126-30
pubmed: 25547035
Sleep Med. 2014 Jan;15(1):111-5
pubmed: 24325809
J Sleep Res. 2007 Sep;16(3):269-75
pubmed: 17716276
Sleep. 2018 Jun 1;41(6):
pubmed: 29522206
Chronobiol Int. 2008 Feb;25(1):145-53
pubmed: 18293155

Auteurs

Damien Leger (D)

Université Paris Descartes, APHP, Hôtel Dieu, Centre du Sommeil et de la Vigilance, Centre de référence hypersomnies rares et EA 7330 VIFASOM, 1 place du Parvis Notre-Dame, 75004 Paris, France.

Lorenzo Tonetti (L)

Department of Psychology, University of Bologna, Viale Berti Pichat 5, 40127 Bologna, Italy.

Caroline Gauriau (C)

Université Paris Descartes, APHP, Hôtel Dieu, Centre du Sommeil et de la Vigilance, Centre de référence hypersomnies rares et EA 7330 VIFASOM, 1 place du Parvis Notre-Dame, 75004 Paris, France.

Brice Faraut (B)

Université Paris Descartes, APHP, Hôtel Dieu, Centre du Sommeil et de la Vigilance, Centre de référence hypersomnies rares et EA 7330 VIFASOM, 1 place du Parvis Notre-Dame, 75004 Paris, France.

Maxime Elbaz (M)

Université Paris Descartes, APHP, Hôtel Dieu, Centre du Sommeil et de la Vigilance, Centre de référence hypersomnies rares et EA 7330 VIFASOM, 1 place du Parvis Notre-Dame, 75004 Paris, France.

Fabien Sauvet (F)

Université Paris Descartes, APHP, Hôtel Dieu, Centre du Sommeil et de la Vigilance, Centre de référence hypersomnies rares et EA 7330 VIFASOM, 1 place du Parvis Notre-Dame, 75004 Paris, France.
Institut de Recherche Biomédicale des Armées (IRBA), Unité Fatigue et Vigilance, BP73, 91223 Brétigny sur Orge, France.

Vincenzo Natale (V)

Department of Psychology, University of Bologna, Viale Berti Pichat 5, 40127 Bologna, Italy.

Classifications MeSH